Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Explore Top Pharmaceutical Products, APIs, Formulations & Intermediates from Verified Suppliers

Fluticasone Propionate

Strength:
0.5 mg/2 mL ampoules, 1 mg/2 mL ampoules

Form: Inhalation suspension for use with nebulizers

Reference Brands: Flixotide Nebules(EU)

View More Get Enquiry

Levosalbutamol

Strength:
0.31 mg/3 mL, 0.63 mg/3 mL, and 1.25 mg/3 mL.

Form: Inhalation Solution

Reference Brands: Xopenex®(US), Levolin Respules(India)

View More Get Enquiry

Formoterol Fumarate /Budesonide

Strength:
DPI: 100 mcg Budesonide / 6 mcg Formoterol, ; MDI: 80 mcg Budesonide / 4.5 mcg Formoterol Fumarate, 160 mcg Budesonide / 4.5 mcg Formoterol Fumarate

Form: Powder For Inhalation(DPI/MDI)

Reference Brands: Symbicort®(US); Symbicort® Turbohaler®, DuoResp® Spiromax®(EU - various strengths available)

View More Get Enquiry

Tiotropium Bromide

Strength:
18 mcg per capsule

Form: Dry Powder for Inhalation (DPI)

Reference Brands: Spiriva® HandiHaler®(US & EU)

View More Get Enquiry

Salmeterol /Fluticasone Propionate

Strength:
DPI (fluticasone/salmeterol): 100/50 mcg, 250/50 mcg, 500/50 mcg; MDI (fluticasone/salmeterol): 45/21 mcg, 115/21 mcg, 230/21 mcg

Form: Powder For Inhalation(DPI/MDI)

Reference Brands: EU & US- DPI: Advair Diskus®, AirDuo® RespiClick® , AirDuo® Digihaler®, Seretide® DiskusAirFluSal® Forspiro; EU & US - MDI: Advair HFA® , Seretide® Evohaler, Viani®

View More Get Enquiry

Glycopyrrolate + Indacaterol

Strength:
Ultibro Breezhaler: Indacaterol 85 mcg + Glycopyrronium 43 mcg

Form: Inhalation powder delivered via Neohaler device/Breezhaler device

Reference Brands: Utibron Neohaler(Dis.cntd in US-2020); Ultibro Breezhaler(EU)

View More Get Enquiry

Terbutaline Sulfate

Strength:
Tab: 2.5 mg, 5 mg; Inj: 1 mg/ml; Inhale: 0.25 mg per inhalation

Form: Tablet, Injection & inhalation

Reference Brands: Brethine® (US) & Bricanyl®(EU)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.